184 related articles for article (PubMed ID: 18205980)
1. Lithium preferentially inhibits adenylyl cyclase V and VII isoforms.
Mann L; Heldman E; Shaltiel G; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Jun; 11(4):533-9. PubMed ID: 18205980
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G
Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557
[TBL] [Abstract][Full Text] [Related]
3. Characterization of adenylyl cyclases in cultured human granulosa cells.
Asbóth G; Price SA; Bellinger J; Ledger W; Barlow DH; Bernal AL
Reproduction; 2001 Feb; 121(2):217-28. PubMed ID: 11226046
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.
Robinson SW; Caron MG
Mol Pharmacol; 1997 Sep; 52(3):508-14. PubMed ID: 9281614
[TBL] [Abstract][Full Text] [Related]
5. Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.
Lee KW; Hong JH; Choi IY; Che Y; Lee JK; Yang SD; Song CW; Kang HS; Lee JH; Noh JS; Shin HS; Han PL
J Neurosci; 2002 Sep; 22(18):7931-40. PubMed ID: 12223546
[TBL] [Abstract][Full Text] [Related]
6. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform.
Thomas JM; Hoffman BB
Mol Pharmacol; 1996 May; 49(5):907-14. PubMed ID: 8622641
[TBL] [Abstract][Full Text] [Related]
8. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism.
Podda MV; Riccardi E; D'Ascenzo M; Azzena GB; Grassi C
Neuroscience; 2010 May; 167(3):678-90. PubMed ID: 20211700
[TBL] [Abstract][Full Text] [Related]
11. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
Kozell LB; Machida CA; Neve RL; Neve KA
J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
[TBL] [Abstract][Full Text] [Related]
12. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
[TBL] [Abstract][Full Text] [Related]
13. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
14. Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase.
Harrison LM; He Y
J Neurosci Res; 2011 Jun; 89(6):874-82. PubMed ID: 21374700
[TBL] [Abstract][Full Text] [Related]
15. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
Kudlacek O; Just H; Korkhov VM; Vartian N; Klinger M; Pankevych H; Yang Q; Nanoff C; Freissmuth M; Boehm S
Neuropsychopharmacology; 2003 Jul; 28(7):1317-27. PubMed ID: 12784121
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
Sasaki T; Kotera J; Omori K
J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
[TBL] [Abstract][Full Text] [Related]
17. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
[TBL] [Abstract][Full Text] [Related]
18. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Heldman E; Vogel Z
Mol Pharmacol; 1998 Aug; 54(2):419-26. PubMed ID: 9687584
[TBL] [Abstract][Full Text] [Related]
20. Dopamine inhibits somatolactin gene expression in tilapia pituitary cells through the dopamine D2 receptors.
Jiang Q; Lian A; He Q
Comp Biochem Physiol A Mol Integr Physiol; 2016 Jul; 197():35-42. PubMed ID: 26970582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
